ANGO vs SBAC · rev $292.5M vs P/E 30, rev $693.7M
AngioDynamics Inc (ANGO) versus SBA Communications Corp (SBAC) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported SBAC revenue for 2024-12-31 was $693.7M. Net income was $748.7M. Revenue was up 3.9% from 2024-09-30 to 2024-12-31. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
ANGO currently screens at market cap $378.5M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Not investment advice. Open the ANGO and SBAC stock pages for the full models.
Not investment advice.